Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks.

Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. Abstract Text:

Deborah Watkins Bruner,Charlene J Bryan,Neil Aaronson,C Craig Blackmore,Michael Brundage,David Cella,Patricia A Ganz,Carolyn Gotay,Pamela S Hinds,Alice B Kornblith,Benjamin Movsas,Jeff Sloan,Lari Wenzel,Giles Whalen, ,

PURPOSE: The objective of this report is to provide a historical overview of and the issues and challenges inherent in the incorporation of patient-reported outcomes (PROs) into multinational cancer clinical trials in the cancer cooperative groups. METHODS: An online survey of 12 cancer cooperative groups from the United States, Canada, and Europe was conducted between June and August of 2006. Each of the cooperative groups designated one respondent, who was a member of one of the PRO committees within the cooperative group. RESULTS: There was a 100% response rate, and all of the cancer clinical trial cooperative groups reported conducting PRO research. PRO research has been conducted in the cancer cooperative groups for an average of 15 years (range, 6 to 30 years), and all groups had multidisciplinary committees focused on the design of PRO end points and the choice of appropriate PRO measures for cancer clinical trials. The cooperative groups reported that 5% to 50% of cancer treatment trials and an estimated 50% to 75% of cancer control trials contained PRO primary and secondary end points. There was considerable heterogeneity among the cooperative groups with respect to the formal and informal policies and procedures or cooperative group culture towards PROs, investigator training/mentorship, and resource availability for the measurement and conduct of PRO research within the individual cooperatives. CONCLUSION: The challenges faced by the cooperative groups to the incorporation of PROs into cancer clinical trials are varied. Some common opportunities for improvement include the adoption of standardized training/mentorship mechanisms for investigators for the conduct of PRO assessments and data collection and the development of minimal criteria for PRO measure acceptability. A positive cultural shift has occurred in most of the cooperative groups related to the incorporation of PROs in clinical trials; however, financial and other resource barriers remain and need to be addressed.

Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. Publishing Authors By Initials

DW Bruner,CJ Bryan,N Aaronson,CC Blackmore,M Brundage,D Cella,PA Ganz,C Gotay,PS Hinds,AB Kornblith,B Movsas,J Sloan,L Wenzel,G Whalen, ,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. Journal Published:

PUBLICATION TYPE: Review

Journal: Journal of clinical oncology : official journal of

VOLUME: 25

Page Numbers: 5051-7

Journal Abbreviation:

ISSN: 1527-7755

DAY: 10

MONTH: Nov

YEAR: 2007

Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8309333

Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks.

AFFILIATION: Radiation Therapy Oncology Group, University of Pennsylvania, School of Nursing; American College of Radiology Imaging Network, Philadelphia, PA 19104-6096, USA. wbruner@nursing .upenn.edu

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Clin Oncol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks Related Publications

• An author's guide to the Guidelines for Authors.
• Anterior pathway for transdiaphragmatic extension of pneumomediastinum.
• Caldwell Radiology of the Abdomen: Lecture. Impact of new imaging methods.
• Cooperation between authors and copy editors: one key to high-quality publications.
• Determination of optical constants using pseudo-Brewster angle and normal incidence reflectance measurements.
• Displaced lateral surface of the liver (Hellmer's sign) secondary to an extraperitoneal fluid collection.
• Editorial: Bone mineral measurement.
• Effect of dibutyltin on ATP levels in human natural killer cells.
• Effect of tributyltin (TBT) on ATP levels in human natural killer (NK) cells: relationship to TBT-induced decreases in NK function.
• Effects of organochlorine pesticides on interleukin secretion from lymphocytes.
• Extraperitoneal spaces.
• Human amygdala responses during presentation of happy and neutral faces: correlations with state anxiety.
• Impediments to clarity: an annotated glossary of rhetorical pratfalls and pitfalls.
• International Skeletal Society: eighteenth annual refresher course, September 1991.
• Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks.
• Knowledge of HIV by health professionals in Kampala, Uganda.
• Liver Imaging--Current Trends in MRI, CT, and US: international symposium and course, June 1990.
• Reduced tissue damage and improved recovery of motor function after traumatic brain injury in mice deficient in complement component C4.
• Society of Thoracic Radiology ninth annual meeting and postgraduate course, May 1991.
• TNF alpha and Fas mediate tissue damage and functional outcome after traumatic brain injury in mice.
• The Fleischner Society 22nd Annual Symposium on Chest Disease: scientific session, May 1992.
• The Society of Cardiovascular and Interventional Radiology: 17th annual scientific meeting, April 1992.
• The Society of Gastrointestinal Radiologists: 20th annual meeting, February 1991.
• The impact of new imaging technology on worldwide health care, research, and teaching: fifth international symposium, August 1992.
• The uncertainty of it all.
• Thoracic imaging, 1992.
• Vowel space parameters.
• Western Neuroradiological Society, 23rd annual meeting: October 1991.
• Why we edit.
• [Proliferation and differentiation of a myogenic line in synthetic media]